Growth Metrics

Quanterix (QTRX) Net Income towards Common Stockholders (2017 - 2026)

Quanterix posted quarterly Net Income towards Common Stockholders of -$17.5 million for Q1 2026, up 14.45% year-on-year from -$15.3 million in Q1 2025, and up 24.12% on a QoQ basis from -$23.1 million in Q4 2025.

Quanterix (QTRX) has 10 years of Net Income towards Common Stockholders data on file, last reported at -$17.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 14.45% year-over-year to -$17.5 million; the trailing twelve-month figure through Mar 2026 stood at -$104.2 million (down 117.64% YoY), and the FY2025 full-year result was -$107.2 million, down 178.09% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$17.5 million, up from -$23.1 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$5.6 million in Q2 2023 and bottomed at -$36.6 million in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$17.5 million (2026), against an average of -$17.1 million.
  • The widest annual swing landed in 2023, when Net Income towards Common Stockholders jumped 81.63%; it then sank 306.29% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$18.2 million in 2022, then jumped by 51.57% to -$8.8 million in 2023, then tumbled by 31.94% to -$11.6 million in 2024, then tumbled by 98.8% to -$23.1 million in 2025, then gained by 24.12% to -$17.5 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$17.5 million (Q1 2026), -$23.1 million (Q4 2025), and -$33.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Quanterix 165.84 Mn 66.57 Mn 15.57 Mn -17.54 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.54 Mn
Dec 31, 2025 -23.12 Mn
Sep 30, 2025 -33.52 Mn
Jun 30, 2025 -30.01 Mn
Mar 31, 2025 -20.50 Mn
Dec 31, 2024 -11.63 Mn
Sep 30, 2024 -8.35 Mn
Jun 30, 2024 -7.39 Mn
Mar 31, 2024 -11.16 Mn
Dec 31, 2023 -8.81 Mn
Sep 30, 2023 -6.72 Mn
Jun 30, 2023 -5.55 Mn
Mar 31, 2023 -7.27 Mn
Dec 31, 2022 -18.20 Mn
Sep 30, 2022 -36.55 Mn
Jun 30, 2022 -26.91 Mn
Mar 31, 2022 -17.92 Mn
Dec 31, 2021 -17.89 Mn
Sep 30, 2021 -15.66 Mn
Jun 30, 2021 -11.90 Mn
Mar 31, 2021 -10.10 Mn
Dec 31, 2020 -9.82 Mn
Sep 30, 2020 2.20 Mn
Jun 30, 2020 -12.30 Mn
Mar 31, 2020 -11.61 Mn
Dec 31, 2019 -10.96 Mn
Sep 30, 2019 -9.87 Mn
Jun 30, 2019 -10.56 Mn
Mar 31, 2019 -9.41 Mn
Dec 31, 2018 -9.33 Mn
Sep 30, 2018 -7.66 Mn
Jun 30, 2018 -7.34 Mn
Mar 31, 2018 -7.20 Mn
Dec 31, 2017 -8.20 Mn
Sep 30, 2017 -7.74 Mn
Jun 30, 2017 -7.75 Mn
Mar 31, 2017 -7.50 Mn